Avon
This article was originally published in The Rose Sheet
Executive Summary
Direct-seller begins construction on $40 mil. manufacturing facility near Narofominsk, Russia to support firm's beauty business in the region. Russia is one of Avon's fastest growing markets, with sales expected to reach $500 mil. in 2007, firm says. The 250,000 square foot facility, expected to open in mid-2004, will employ over 800 workers and produce 185 mil. units of cosmetic products, Avon says. Items manufactured at the plant will be sold in Russia through Avon's 194,000 consultants, and in Ukraine and Kazakhstan. Avon has had a presence in Russia since 1995, with regional sales of $142 mil. in 2002...
You may also be interested in...
Avon
Direct-seller remains confident business will reach $8.5 bil. by 2007 with 20% operating margin, Exec VP-Asia Pacific, Europe, Middle East & Africa Robert Toth reports during Merrill Lynch Global Branded Consumer Products Conference Oct. 1. Exec says Avon will focus on Central and Eastern Europe as key areas to contribute to growth, highlights Russia as the biggest opportunity in the group. Firm recently announced plans to open $40 mil. manufacturing facility outside Moscow in mid-2004 (1"The Rose Sheet" Sept. 29, 2003, In Brief). Other nations Avon views as strategic regional opportunities include Turkey, Kazakhstan and Bosnia, Toth says...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.